dx 9065a has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
| Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (n-formylmethionine leucyl-phenylalanine) | Trials (n-formylmethionine leucyl-phenylalanine) | Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine) |
|---|---|---|---|---|---|
| 92 | 7 | 8 | 6,716 | 53 | 356 |
| Protein | Taxonomy | dx 9065a (IC50) | n-formylmethionine leucyl-phenylalanine (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enkhbaatar, P; Murakami, K; Okabe, H; Okabe, K; Okajima, K; Uchiba, M; Yamaguchi, Y | 1 |
1 other study(ies) available for dx 9065a and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.
Topics: Animals; Anticoagulants; Capillary Permeability; Dansyl Compounds; Factor VIIa; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; In Vitro Techniques; Leukocytes; Lipopolysaccharides; Lipoproteins; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Naphthalenes; Neutrophil Activation; Peroxidase; Propionates; Pulmonary Edema; Rats; Rats, Wistar; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2000 |